Global Automated Biochemical Analyzers Revenue Is Nearly 3131 M USD In 2017
Thursday, 08 Nov, 2018
In the last several years, global market of Automated Biochemical Analyzers developed rapidly, with an average growth rate of 5.18% during 2013 to 2017. In 2017, global revenue of Automated Biochemical Analyzers is nearly 3131 M USD; the actual sales are about 111428 Unit.
The global average price of Automated Biochemical Analyzers is in the decreasing trend, from 29.1 K USD/Unit in 2013 to 28.1 K USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Automated Biochemical Analyzers includes Floor-standing and Bench-top, and the proportion of Floor-standing in 2017 is about 62%.
Automated Biochemical Analyzers is widely used in hospitals, clinics and other field. The most proportion of Automated Biochemical Analyzers is used in hospitals and the proportion in 2017 is 57%.
North America is the largest consumption place, with a consumption market share nearly 30% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 27%.
Market competition is not intense. Roche, Danaher, Siemens Healthcare, Abbott, Hitachi, Mindray Medical, Thermo Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.